| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in GUTS over the last quarter tilts toward buying: insiders added a net 64,516 shares worth roughly $40K.
Classified under Biotechnology (Health Care sector), GUTS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.6K | $394.7K | - | |
| Dir | 149.1K | $92.2K | - | |
| Dir | 40.9K | $34.8K | - | |
| Dir | 35.0K | $25.5K | - | |
| CFO | 20.0K | $13.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Bradley William | Director | Buy | 16,129 | $1.26 | $20,358.02 | New | +88.4% | -61.3% | |
| Mar 13, 2025 | Conaway Samuel | Director | Buy | 8,550 | $1.17 | $9,964.17 | New | +88.4% | -61.3% | |
| Jan 31, 2025 | Rajagopalan Harith74 | Chief Executive Officer | Sale+OE10b5-1 | 111,920 | $1.84 | $206,003.48 | -18.6% | -31.0% | -75.0% | |
| Jan 31, 2025 | Caplan Jay David79 | President, Chief Product Officer | Sale+OE10b5-1 | 43,818 | $1.88 | $82,265.83 | -22.2% | -31.0% | -75.0% | |
| Nov 11, 2024 | Rajagopalan Harith74 | Chief Executive Officer | Sale+OE | 96,517 | $2.47 | $238,358.38 | -16.4% | -40.6% | -56.2% | |
| Nov 11, 2024 | Caplan Jay David79 | President, Chief Product Officer | Sale+OE | 64,197 | $2.47 | $158,540.91 | -29.5% | -40.6% | -56.2% | |
| Sep 12, 2024 | Caplan Jay David79 | President, Chief Product Officer | Sale+OE | 65,000 | $2.90 | $188,474.00 | -68.1% | -20.3% | -64.3% | |
| Feb 6, 2024 | Royan Ajay | Director, 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +36.3% | -39.0% | -84.2% | |
| Feb 6, 2024 | Mithril LP | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +36.3% | -39.0% | -84.2% | |
| Feb 6, 2024 | Elia Marc | Director | Buy | 466,666 | $15.00 | $6,999,990.00 | +33.6% | -39.0% | -84.2% |